This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Subbegowda, R. Articles by Frommel, T. O. Search for Related Content PubMed Articles by Subbegowda, R. Articles by Frommel, T. O.

Aspirin Toxicity for Human Colonic Tumor Cells Results from Necrosis and Is Accompanied by Cell Cycle Arrest¹

Department of Medicine, Loyola University Medical Center, Maywood, Illinois 60153

Chemoprevention of colorectal cancer using aspirin has been demonstrated in rodents and has been suggested by data from epidemiological studies. The mechanism that accounts for this prevention is unknown, but it is thought to relate to an irreversible inhibition of cyclooxygenase and, subsequently, prostaglandin production. The effect of aspirin on the growth of human colonic tumor cells was determined in an effort to gain insight into a possible mechanism of action. In the two cell lines studied, SW 620 and HT-29, we observed a significant dose- and time-dependent increase in aspirin toxicity in a concentration range of 1.25–10 mM. This result was independent of prostaglandin production, because there was no measurable prostaglandin E₂ in cell culture medium. As compared with controls, cells in cultures that contained aspirin were not detached, which suggests that the mechanism of cell death was not apoptosis. Flow cytometric analysis revealed an increase in S phase and G₂-M populations as well as the number of subdiploid nuclei in cultures treated with high-dose aspirin. Confirmation that cells were undergoing necrosis in response to aspirin was evident from the presence of cells that bound annexin V and accumulated propidium iodide in the absence of a population that bound annexin alone. The results suggest that aspirin induces cell cycle arrest and causes necrosis at high concentrations in vitro, but does not induce apoptosis. Collectively, these two events, necrosis and cell cycle arrest, may contribute to the chemopreventive effect that seems to result from long-term administration of aspirin in vivo.

¹ Supported by Loyola Intramural grant.

² To whom requests for reprints should be addressed, at Rush-Presbyterian-St. Luke's Medical Center, Rush Cancer Institute, 1725 West Harrison Street, Suite 809, Professional Building 1, Chicago, IL 60153.

Received 1/12/98. Accepted 5/ 1/98.

This article has been cited by other articles:

				S.-K. Seo, H.-O. Jin, H.-C. Lee, S.-H. Woo, E.-S. Kim, D.-H. Yoo, S.-J. Lee, S. An, C.-H. Rhee, S.-I. Hong, et al. Combined Effects of Sulindac and Suberoylanilide Hydroxamic Acid on Apoptosis Induction in Human Lung Cancer Cells Mol. Pharmacol., March 1, 2008; 73(3): 1005 - 1012. [Abstract] [Full Text] [PDF]

				H. C. Thoms, M. G. Dunlop, and L. A. Stark p38-Mediated Inactivation of Cyclin D1/Cyclin-Dependent Kinase 4 Stimulates Nucleolar Translocation of RelA and Apoptosis in Colorectal Cancer Cells Cancer Res., February 15, 2007; 67(4): 1660 - 1669. [Abstract] [Full Text] [PDF]

				T. Minami, M. Adachi, R. Kawamura, Y. Zhang, Y. Shinomura, and K. Imai Sulindac Enhances the Proteasome Inhibitor Bortezomib-Mediated Oxidative Stress and Anticancer Activity Clin. Cancer Res., July 15, 2005; 11(14): 5248 - 5256. [Abstract] [Full Text] [PDF]

				Q. Gu, J. D. Wang, H. H.X. Xia, M. C.M. Lin, H. He, B. Zou, S. P. Tu, Y. Yang, X. G. Liu, S. K. Lam, et al. Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer Carcinogenesis, March 1, 2005; 26(3): 541 - 546. [Abstract] [Full Text] [PDF]

				A. Goel, D. K. Chang, L. Ricciardiello, C. Gasche, and C. R. Boland A Novel Mechanism for Aspirin-mediated Growth Inhibition of Human Colon Cancer Cells Clin. Cancer Res., January 1, 2003; 9(1): 383 - 390. [Abstract] [Full Text] [PDF]

				A. F. Soriano, B. Helfrich, D. C. Chan, L. E. Heasley, P. A. Bunn Jr., and T.-C. Chou Synergistic Effects of New Chemopreventive Agents and Conventional Cytotoxic Agents against Human Lung Cancer Cell Lines Cancer Res., December 1, 1999; 59(24): 6178 - 6184. [Abstract] [Full Text] [PDF]